Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fungus – except allergen – or component thereof or substance...
Patent
1981-03-10
1983-09-13
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Fungus, except allergen, or component thereof or substance...
A61K 3140
Patent
active
044042191
ABSTRACT:
A series of phenylguanidine base compounds and their pharmaceutically acceptable acid addition salts have been found to be active as oral hypoglycemic agents. Preferred member compounds include N,N'-diphenyl-1-pyrrolidinocarboxamidine, N-phenyl-N'-methyl-N'-phenyl-1-pyrrolidinocarboxamidine and N-phenyl-N'-(p-chlorophenyl)-1-pyrrolidinocarboxamidine, and their hydrohalide acid addition salts. Synthetic routes leading to these compounds are described.
REFERENCES:
patent: 4269837 (1981-05-01), Watt et al.
Knuth Charles J.
Pfizer Inc.
Richardson Peter C.
Waddell Frederick E.
LandOfFree
Phenylguanidine therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenylguanidine therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylguanidine therapeutic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1729820